A new platform has been launched today to speed up the sharing of research results and increase the amount of data available in the public domain.
MQ is one of 23 members of the Association of Medical Research Charities (AMRC) who have worked in collaboration on AMRC Open Research. All of MQ’s funded researchers will have access to the platform, enabling them to publish any aspect of the research we fund in an open access format that includes the raw data and expert peer reviews.
By making articles available in a matter of days, rather than the typical months or years that traditional publishing can take, and by including access to wider data, the new platform will help accelerate our understanding of conditions and diseases that affect so many lives.
It also aims to enable researchers and charities to maximise the impact of research and the value of donations received, by allowing every research output to be rapidly and openly shared.
AMRC Open Research will use services developed by F1000 and a publication process first used on F1000Research. This process has since been adopted by many leading research funders and institutions around the world including Wellcome, the Gates Foundation and the African Academy of Sciences, who have recently launched their own platforms.
Dr Sophie Dix, MQ’s Research Director said: “Rapid sharing of learnings and data is a vital if we are to achieve much-needed breakthroughs in the way we understand, treat and prevent mental and physical health conditions. The potential of AMRC Open Research is huge – allowing us to maximise the impact of every donation we invest in research so that we can truly transform lives.
Aisling Burnand, Chief Executive of AMRC, said: “All too often the results of research are published slowly, held behind paywalls, or never published at all. By launching this platform the participating charities are helping to ensure that all results of the research they fund can be rapidly and widely shared to limit duplication of effort, accelerate the progress of research and most importantly bring benefits to patients sooner.”
More information on the Platform is available on the AMRC website.
Last updated: 1 May 2018